Since it joined the list
$ARVN landed on the list 2026-03-02, down 29.3% from its 52-week high that day — now down -39.1%.
That's 28.4 percentage points deeper than the day it joined. It bottomed 63.1% below that high along the way.
Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
ARVN qualifies for the Red List on decline depth.
The structural read
What price action says about ARVN.
ARVN qualifies for the Red List on decline depth — down -39.1% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause that often precedes further breakdown. Depth plus recency: this is the pattern many investors call a falling knife.
Cross-confirmation: also showing 3/5 bearish time frames.
Cross-confirmation: decline sigma also reads 7.5σ over 20 bars.
Upstream TFC read: weak alignment, current phase daily. Last bar types — daily 2D (green), weekly 1 (red), monthly 2D (red).
Earnings on file: 2026-05-12. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
Sector context · Healthcare
194 other Healthcare tickers are on Broken Stocks.
Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →
Questions about ARVN
What people ask.
Why is ARVN on Broken Stocks?
ARVN qualifies for the Red List on decline depth. It is down -39.1% from its rolling 252-day high of $14.51, set on 2026-03-10 — 79d ago.
Is ARVN a falling knife?
By the most common technical definition — a steep, recent breakdown from a fresh high — yes. ARVN is down -39.1% from its 52-week high of $14.51, set 79d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.
Is ARVN a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is ARVN trading inside its 52-week range?
At $8.84, ARVN sits 32.9% of the way from its 52-week low ($6.06) to its 52-week high ($14.51). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has ARVN been declining?
The current 39.1% decline accrued over 79d, which annualizes to roughly -180.7% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does ARVN compare to its sector?
There are 194 other Healthcare tickers on Broken Stocks: 88 Red, 47 Amber, 59 Watch, with 108 showing recovering structural signals. Median sector decline is -35.8% — ARVN's decline is deeper than the sector median.
Does ARVN's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-12) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.